BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2455590)

  • 1. Analysis of the levels of CA125, carcinoembryonic antigen, and CA19-9 in the cervical mucus for a detection of cervical adenocarcinoma.
    Fujii S; Konishi I; Nanbu Y; Nonogaki H; Kobayashi F; Sagawa N; Mori T; Endo K
    Cancer; 1988 Aug; 62(3):541-7. PubMed ID: 2455590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of the levels of CA125, CA19-9, and CEA in the cervical mucus helps a diagnosis of cervical adenocarcinomas].
    Fujii S; Konishi I; Nanbu Y; Sagawa N; Nonogaki H; Mori T
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Dec; 39(12):2193-4. PubMed ID: 3480920
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis of the levels of CA125, CEA and CA19-9 in the cervical mucus samples obtained at various phases of the menstrual cycle and with inflammatory diseases of the uterine cervix].
    Nanbu Y; Fujii S; Konishi I; Nonogaki H; Kobayashi F; Sagawa N; Mori T
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Oct; 40(10):1519-24. PubMed ID: 3225482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CA19-9, CA125 and CEA in endometrial carcinoma tissue and its relation to hormone receptor content and histological grading.
    Neunteufel W; Bieglmayer C; Breitenecker G
    Arch Gynecol Obstet; 1988; 244(1):47-52. PubMed ID: 2853610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histochemical analysis of uterine cervical adenocarcinoma with reference to mucosubstances and distribution of CEA, CA125 and CA19-9].
    Maruyama C; Yamamichi N; Konishi F
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):429-36. PubMed ID: 3163714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
    Kataoka A; Yakushiji M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas.
    Steinberg WM; Gelfand R; Anderson KK; Glenn J; Kurtzman SH; Sindelar WF; Toskes PP
    Gastroenterology; 1986 Feb; 90(2):343-9. PubMed ID: 2416628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal bronchial mucus contains high levels of cancer-associated antigens, CA125, CA19-9, and carcinoembryonic antigen.
    Matsuoka Y; Endo K; Kawamura Y; Yoshida T; Saga T; Watanabe Y; Koizumi M; Nakashima T; Konishi J; Yamaguchi N
    Cancer; 1990 Feb; 65(3):506-10. PubMed ID: 2297641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma.
    Yousef A; Yousef M; Zeineddine MA; More A; Fanaeian M; Chowdhury S; Knafl M; Edelkamp P; Ito I; Gu Y; Pattalachinti V; Naini ZA; Zeineddine FA; Peterson J; Alfaro K; Foo WC; Jin J; Bhutiani N; Higbie V; Scally CP; Kee B; Kopetz S; Goldstein D; Strach M; Williamson A; Aziz O; Barriuso J; Uppal A; White MG; Helmink B; Fournier KF; Raghav KP; Taggart MW; Overman MJ; Shen JP
    JAMA Netw Open; 2024 Feb; 7(2):e240260. PubMed ID: 38416491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical carcinoma: a comparison of four potential biochemical tumor markers.
    Dodd JK; Henry RJ; Tyler JP; Houghton CR
    Gynecol Oncol; 1989 Feb; 32(2):248-52. PubMed ID: 2910788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical comparison of new monoclonal antibody 1C5 and carcinoembryonic antigen in the differential diagnosis of adenocarcinoma of the uterine cervix.
    Kudo R; Sasano H; Koizumi M; Orenstein JM; Silverberg SG
    Int J Gynecol Pathol; 1990; 9(4):325-36. PubMed ID: 1700970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, and squamous cell carcinoma antigen in the detection of cervical cancers.
    Lam CP; Yuan CC; Jeng FS; Tsai LC; Yeh SH; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jul; 50(1):7-13. PubMed ID: 1326391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of CEA, CA19-9, and DF3 in esophageal carcinoma limited to the submucosal layer.
    Ikeda Y; Kuwano H; Ikebe M; Baba K; Toh Y; Adachi Y; Sugimachi K
    J Surg Oncol; 1994 May; 56(1):7-12. PubMed ID: 8176946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma of the uterine cervix. Prognostic significance of pretreatment serum CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen levels in relation to clinical and histopathologic tumor characteristics.
    Duk JM; De Bruijn HW; Groenier KH; Fleuren GJ; Aalders JG
    Cancer; 1990 Apr; 65(8):1830-7. PubMed ID: 2317761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distribution of mucins, carcinoembryonic antigen, and mucus-associated antigens in endocervical and endometrial adenocarcinomas.
    Maes G; Fleuren GJ; Bara J; Nap M
    Int J Gynecol Pathol; 1988; 7(2):112-22. PubMed ID: 3294194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site.
    Brown RW; Campagna LB; Dunn JK; Cagle PT
    Am J Clin Pathol; 1997 Jan; 107(1):12-9. PubMed ID: 8980361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
    Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
    Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
    Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
    Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation of histological tumor type of the cervix expressed in different tumor markers in the serum.
    Aalders JG; de Bruijn HW; Oosterhuis JW; Duk JM
    Gynecol Oncol; 1990 Jan; 36(1):110-2. PubMed ID: 2295441
    [No Abstract]   [Full Text] [Related]  

  • 20. Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen.
    Gupta MK; Arciaga R; Bocci L; Tubbs R; Bukowski R; Deodhar SD
    Cancer; 1985 Jul; 56(2):277-83. PubMed ID: 2408729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.